Searched for
BHEL RESULTS
BHEL, SAIL at risk of losing Maharatna tagTwo major Indian public sector companies, BHEL and SAIL, face a one-year deadline to improve their financial performance. Failure to meet p...
Avoid chasing IT rally, focus on power and steel plays: Neeraj DewanMarket expert Neeraj Dewan advises selective investing amid volatility, favoring power, energy infrastructure, steel, aviation, commercial ...
Carlsberg bolsters India leadership ahead of planned IPO, appoints four new board membersCarlsberg India IPO: Carlsberg India is preparing for stock market debut. The company has added four directors to its board and converted t...
Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...
6 midcap stocks post 50%+ EBITDA growth in March '26 quarterNSE midcap stocks showed strong operational performance with several companies reporting over 50% EBITDA growth in Q4 FY26. Led by firms li...
Smallcaps continue to draw domestic flows, stock selection key: Sandip SabharwalIndian equity markets show resilience post-election results. Market expert Sandip Sabharwal notes that governance and policy continuity are...
BHEL shares jump 3%, rally 10% in two days after Q4 results. What Morgan Stanley, other brokerages sayBharat Heavy Electricals (BHEL) share price surged over 10% in two days following robust Q4 FY26 earnings, with net profit soaring 156% yea...
BHEL shares soar 13% after Q4 net profit rockets 156% YoY to Rs 1,290 crore, revenue up 37%BHEL Q4 Results FY26: Bharat Heavy Electricals Ltd (BHEL) shares surged over 13% after reporting a robust March quarter with a 156% jump in...
West Bengal election results put these 43 stocks under spotlight. Will BJP's win be a trigger?Early West Bengal election trends putting BJP ahead of TMC have pushed stocks like Bandhan Bank, CESC, and Berger Paints into focus. Invest...
Ahead of Market: 10 things that will decide stock market action on ThursdayIndian stock markets saw a strong upward trend on Wednesday. The Nifty 50 and Sensex both closed higher, driven by gains in auto, FMCG, and...
BHEL shares rally 5% after reporting 18% YoY rise in FY26 provisional turnoverShares of Bharat Heavy Electricals Limited rallied nearly 5% after the company posted an 18% YoY rise in its FY26 provisional turnover to R...
BHEL Q3 Results: Profit more than triples to Rs 382 crore; revenue jumps 16% YoYBHEL reported a sharp turnaround in the December quarter, with net profit surging 206% year-on-year to Rs 382 crore, aided by stronger exec...
BHEL posts 19% revenue growth to Rs 27,350 cr in FY25, hits record order inflowsBharat Heavy Electricals (BHEL), the state-run engineering and manufacturing major, today reported a 19% year-on-year (YoY) rise in provisi...
BHEL Q2 Results: Co swings to black, posts Rs 106 crore PAT vs loss year-agoBHEL Q2 Results FY25: Bharat Heavy Electricals Limited (BHEL) reported a consolidated net profit of ₹106 crore for the September quarter, a...
BHEL Q3 Results: PAT jumps 55% YoY to Rs 42 croreSegment-wise, revenue from power came in at Rs 3,992 crore, 7% higher compared with Rs 3,723 crore reported in the third quarter of last ye...
BHEL Q1 Results: Loss narrows to Rs 188 crore despite 63% rise in salesThis is despite the company reporting a 63.35 per cent YoY rise in sales at Rs 4,449.49 crore compared with Rs 2,723.82 crore in the same q...
BHEL Q2 results: Loss narrows to Rs 46 croreIt incurred a net loss of Rs 552.38 crore in the year-ago period, a BSE filing stated.
BHEL Q1 results: Co's net loss narrows to Rs 448 croreTotal income in the quarter rose to Rs 2,966.77 crore from Rs 2,086.43 crore.
BHEL March quarter loss narrows to Rs 1,036 crTotal income during January-March 2021 rose to Rs 7,245.16 crore, from Rs 5,166.64 crore in the year-ago period.
Expect to enter a new bull market in 2014: Andrew Holland, Ambit Investment AdvisorsPE multiples in the consumer sector is too high and there is no room for errors. On pharma there are regulatory overhangs on the whole sect...